Hydroxyzine Hydrochloride Tablets had U.S. sales of approximately $55 million for the 12 months ending March 31, 2010, according to IMS Health. Currently, Mylan has 138 ANDAs pending FDA approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback